Novel Oral Anticoagulants for Stroke Prophylaxis and Venous Thromboembolism Prevention and Treatment

Novel Oral Anticoagulants for Stroke Prophylaxis and Venous Thromboembolism Prevention and Treatment

Novel oral anticoagulants (NOACs) are becoming popular management options for stroke prophylaxis in nonvalvular atrial fibrillation as well as deep vein thrombosis and pulmonary embolism treatment and prophylaxis. NOACs have similar efficacy to warfarin along with noninferior safety profiles. Patien...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Patient-Centered Research and Reviews 2015-08, Vol.2 (3), p.139-146
1. Verfasser: Alsayegh, Laith G
Format: Artikel
Sprache:eng
Schlagworte:
apixaban
atrial fibrillation
dabigatran
deep vein thrombosis
edoxaban
Eliquis
Lixiana
novel oral anticoagulants
Pradaxa
pulmonary embolism
Review
rivaroxaban
Savaysa
Xarelto
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Novel oral anticoagulants (NOACs) are becoming popular management options for stroke prophylaxis in nonvalvular atrial fibrillation as well as deep vein thrombosis and pulmonary embolism treatment and prophylaxis. NOACs have similar efficacy to warfarin along with noninferior safety profiles. Patient comorbidities, size, renal and hepatic function, and concomitant drug regimen play a role in which NOAC a physician may choose.
ISSN:2330-0698
2330-0698
DOI:10.17294/2330-0698.1055